America is aging. People are leading longer, healthier lives; a contributing factor to an increase in the proportion of the population over the age of 65. In 2010, older Americans make up 13% of the total population. By 2050, this figure is estimated to grow to 20% – increasing the burden placed on society.
Today’s Seniors are happy, active, and living in the communities of their choice. This independence, which is highly valued, is sustained in part through the efforts of informal caregivers and home and community-based services. While they feel good, the majority of Seniors are living with at least one chronic condition.
Spending on health care in the U.S. is on the rise and it is largely understood that the population with multiple chronic illnesses drives the majority of these costs. What is now being realized is that the majority of the chronically ill population is made up of frail Seniors. Many of these chronic diseases are preventable or, at the very least, their burden can be greatly reduced.
In, “The Aging Population - How and Where to Succeed with the Over 50 Crowd”, CBR Pharma Insights examines the opportunities that exist for pharmaceutical companies to provide support to the health and well-being of the older population groups. Additionally, insights and analysis are provided on the key measures & diseases that make this growing patient segment an essential component of any pharmaceutical company’s future plans.
Please Note: This product is delivered as a zip file
Scope
- Review of the population statistics including projections, changes in life expectancy amd dependency ratio
- Trends in healthcare spending
- Review of diseases impacting aging populations
- Competitive landscape
Key Reasons to Purchase
- Analyze the cost burdens associated with the aging population and how your company can impact them through new, innovative medicines and services
- Assess the role that your company can have in supporting the health & well being of the aging population
- Understand the growth rates & cost components of this population to help forecast your potential opportunities for future revenue
- Identify where you may have gaps in your product portfolio and where you could drive potential future partnerships
- Understand new, innovative ways to reach your older patient segments and the impact that health care reform will have on them going forward
Table Of Contents
Executive Summary
Population Statistics
Population Projections for the ‘Aging Cohort” and Subgroups
Changes In Average Life Expectancy
Dependency Ratio as an Indication of Burden
The Daily Lives of Older Americans
Attitudes and Activities of Older Americans
Impact of Healthier Lifestyle and Extended Duration of Independent Living
Nursing Home Population Levels
Daily Living Limitations
Assistance of Informal Care Givers
Prevalence of Chronic Conditions
Use of Technology (i.e. internet, cell phones) and the Enhanced Features that Accompany It (i.e. social networking sites)
Impact of Changes From Health Care Reform
Healthcare Spending
Trends in Health Spending
Costs Associated with Various Long Term Care Arrangements
Burden of Select Conditions
Strategies to Decrease Health Related Costs
Opportunities for Pharmaceutical Companies to Contribute to The Effort
Review of Diseases Impacting Aging Populations
Brief Description of Most Prevalent Conditions by Therapeutic Category
Risk Factors and Potential Outcomes of Select Conditions
Pipeline Overview
Companies Actively Involved In This Space
Competitive Landscape
Profile of Select Companies With Aging Populations as a Core Market
Novartis
Sanofi-Aventis
Merck & Takeda
Appendix
List Of Table
NA
List Of Figures
NA
